PT-141 (Bremelanotide): Complete Mechanism & Clinical Evidence Guide
pt-141-bremelanotide-complete-mechanism-clinical-evidence-guide">PT-141 (Bremelanotide): Complete Mechanism & Clinical Evidence Guide
Key Takeaways
- PT-141 (bremelanotide) is an FDA-approved melanocortin receptor agonist that works through the central nervous system
- Clinical trials show significant efficacy in treating hypoactive sexual desire disorder in